Brown BE - Search Results

1

Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease.

Leung C, Herath CB, Jia Z, Andrikopoulos S, Brown BE, Davies MJ, Rivera LR, Furness JB, Forbes JM, Angus PW. Leung C, et al. Among authors: brown be. World J Gastroenterol. 2016 Sep 21;22(35):8026-40. doi: 10.3748/wjg.v22.i35.8026. World J Gastroenterol. 2016. PMID: 27672297 Free PMC article.

2

Apolipoprotein A-I glycation by glucose and reactive aldehydes alters phospholipid affinity but not cholesterol export from lipid-laden macrophages.

Brown BE, Nobecourt E, Zeng J, Jenkins AJ, Rye KA, Davies MJ. Brown BE, et al. PLoS One. 2013 May 31;8(5):e65430. doi: 10.1371/journal.pone.0065430. Print 2013. PLoS One. 2013. PMID: 23741493 Free PMC article.

3

Glycation of low-density lipoprotein results in the time-dependent accumulation of cholesteryl esters and apolipoprotein B-100 protein in primary human monocyte-derived macrophages.

Brown BE, Rashid I, van Reyk DM, Davies MJ. Brown BE, et al. FEBS J. 2007 Mar;274(6):1530-41. doi: 10.1111/j.1742-4658.2007.05699.x. FEBS J. 2007. PMID: 17480204 Free article.

4

Glycation of low-density lipoproteins by methylglyoxal and glycolaldehyde gives rise to the in vitro formation of lipid-laden cells.

Brown BE, Dean RT, Davies MJ. Brown BE, et al. Diabetologia. 2005 Feb;48(2):361-9. doi: 10.1007/s00125-004-1648-4. Epub 2005 Jan 20. Diabetologia. 2005. PMID: 15660260 Free article.

5

Glycation and glycoxidation of low-density lipoproteins by glucose and low-molecular mass aldehydes. Formation of modified and oxidized particles.

Knott HM, Brown BE, Davies MJ, Dean RT. Knott HM, et al. Among authors: brown be. Eur J Biochem. 2003 Sep;270(17):3572-82. doi: 10.1046/j.1432-1033.2003.03742.x. Eur J Biochem. 2003. PMID: 12919321 Free article.

6

Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I.

Nobécourt E, Tabet F, Lambert G, Puranik R, Bao S, Yan L, Davies MJ, Brown BE, Jenkins AJ, Dusting GJ, Bonnet DJ, Curtiss LK, Barter PJ, Rye KA. Nobécourt E, et al. Among authors: brown be. Arterioscler Thromb Vasc Biol. 2010 Apr;30(4):766-72. doi: 10.1161/ATVBAHA.109.201715. Epub 2010 Jan 28. Arterioscler Thromb Vasc Biol. 2010. PMID: 20110571 Free PMC article.

7

Supplementation with carnosine decreases plasma triglycerides and modulates atherosclerotic plaque composition in diabetic apo E(-/-) mice.

Brown BE, Kim CH, Torpy FR, Bursill CA, McRobb LS, Heather AK, Davies MJ, van Reyk DM. Brown BE, et al. Atherosclerosis. 2014 Feb;232(2):403-9. doi: 10.1016/j.atherosclerosis.2013.11.068. Epub 2013 Dec 18. Atherosclerosis. 2014. PMID: 24468155

8

Role of Myeloperoxidase Oxidants in the Modulation of Cellular Lysosomal Enzyme Function: A Contributing Factor to Macrophage Dysfunction in Atherosclerosis?

Ismael FO, Barrett TJ, Sheipouri D, Brown BE, Davies MJ, Hawkins CL. Ismael FO, et al. Among authors: brown be. PLoS One. 2016 Dec 20;11(12):e0168844. doi: 10.1371/journal.pone.0168844. eCollection 2016. PLoS One. 2016. PMID: 27997605 Free PMC article.

9

Hypochlorite- and hypobromite-mediated radical formation and its role in cell lysis.

Hawkins CL, Brown BE, Davies MJ. Hawkins CL, et al. Among authors: brown be. Arch Biochem Biophys. 2001 Nov 15;395(2):137-45. doi: 10.1006/abbi.2001.2581. Arch Biochem Biophys. 2001. PMID: 11697850

10

Myeloperoxidase-derived oxidants modify apolipoprotein A-I and generate dysfunctional high-density lipoproteins: comparison of hypothiocyanous acid (HOSCN) with hypochlorous acid (HOCl).

Hadfield KA, Pattison DI, Brown BE, Hou L, Rye KA, Davies MJ, Hawkins CL. Hadfield KA, et al. Among authors: brown be. Biochem J. 2013 Jan 15;449(2):531-42. doi: 10.1042/BJ20121210. Biochem J. 2013. PMID: 23088652

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

117 results

Search Page